Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Bladder Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Genitourinary System Neoplasm
Urinary System Neoplasm
Urinary Tract Neoplasm
Bladder Neoplasm

Subtype

Bladder Neoplasm

CI-CAN-00001978Explore in graph →

Non-malignant390 active trials10 approved drugs25 evidence items

NCIt: C2901
MeSH: D001749

Overview
Statistics
Survival
Genomics19
Variants & evidence25
Drugs15
Trials1701
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (145)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 126–145 of 145 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy.
· Eur Urol · 2016 · PMID 25636205 · validated civic_curation pubmed
Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders.
· Eur J Hum Genet · 2002 · PMID 12461689 · validated civic_curation pubmed
Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b.
· Carcinogenesis · 2006 · PMID 16338952 · validated civic_curation pubmed
Identification of targetable FGFR gene fusions in diverse cancers.
· Cancer Discov · 2013 · PMID 23558953 · validated civic_curation pubmed
Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo.
· Br J Cancer · 2011 · PMID 21119661 · validated civic_curation pubmed
Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer.
· Oncogene · 2007 · PMID 17384684 · validated civic_curation pubmed
Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner.
· Oncogene · 2009 · PMID 19749790 · validated civic_curation pubmed

Showing 126–145 of 145 publications

← Previous
1
…
5
6
Next →

Damrauer et al. Nat Commun. 2022

· 2022 · PMID 36333289 · validated cbioportal_study pubmed

Guo et al. Nat Genet 2013

· 2013 · PMID 24121792 · validated cbioportal_study pubmed

Faltas and Prandi, Nature Genetics 2016

· 2016 · PMID 27749842 · validated cbioportal_study pubmed

Van Allen et al. Cancer Discov 2014

· 2014 · PMID 25096233 · validated cbioportal_study pubmed

Iyer, Gopa et al. JCO precision oncology 2024

· 2024 · PMID 39499893 · validated cbioportal_study pubmed

Brendan J et al. Eur Urol Open Sci 2025

· 2025 · PMID 40256659 · validated cbioportal_study pubmed

Pietzak et al. Eur Urol 2019

· 2019 · PMID 30290956 · validated cbioportal_study pubmed

Iyer et al. J Clin Oncol 2013

· 2013 · PMID 23897969 · validated cbioportal_study pubmed

Kim et al. Eur Urol 2015

· 2015 · PMID 25092538 · validated cbioportal_study pubmed

Pietzak et al. Eur Urol 2017

· 2017 · PMID 28583311 · validated cbioportal_study pubmed

Al-Ahmadie et al. Nat Genet 2016

· 2016 · PMID 26901067 · validated cbioportal_study pubmed

TCGA, Nature 2014

· 2014 · PMID 24476821 · validated cbioportal_study pubmed

Robertson et al. Cell 2017

· 2017 · PMID 28988769 · validated cbioportal_study pubmed